The transferability of the carbapenem resistance phenotype was determined by conjugation experiments (Lorenzo-Diaz and Espinosa, 2009 (
link)) using the streptomycin-resistant
E. coli C600 strain. Transconjugants were chosen on MacConkey agar plates (Huankai Co. Ltd., Guangzhou, China) supplemented with cefotaxime (1 mg/L) and streptomycin (1,500 mg/L).
The electrotransformation experiments (Choi et al., 2006 (
link)) were further performed for isolates that failed conjugation experiments. In brief, plasmid DNA was extracted using a
QIAPrep Plasmid Midi Kit (QIAGEN, Hilden, Germany) and transformed into electro-competent
E. coli DH5α (TaKaRa Biotechnology, Dalian, China). electrotransformants were selected on LB agar plates (Huankai Co. Ltd., Guangzhou, China) supplemented with cefotaxime (1 mg/L).
We further confirmed the transconjugants or electrotransformants by PCR for the
blaKPC-2 gene and tested for antimicrobial susceptibility as described above.
Chen Y., Yang R., Guo P., Liu P., Deng J., Wu Z., Wu Q., Huang J, & Liao K. (2023). Dynamic evolution of ceftazidime–avibactam resistance due to interchanges between blaKPC-2 and blaKPC-145 during treatment of Klebsiella pneumoniae infection. Frontiers in Cellular and Infection Microbiology, 13, 1244511.